BACKGROUND: Diffuse large B cell lymphoma (DLBCL) is the most common subtype of
Non-Hodgkins lymphomas (NHL). The outcome of these patients shows a wide variation …

Peptide antibodies, with their high specificities and affinities, are invaluable reagents for
peptide and protein recognition in biological specimens. Depending on the application and …

Survivin, a member of the inhibitor of apoptosis protein family, is overexpressed in a variety
of human neoplasms. The prognostic significance of survivin expression in diffuse large B …

Background: Apoptosis‐related proteins might play an important role in the pathogenesis of
lymphoma and sensibility to chemotherapy (CH) in patients with non‐Hodgkin's lymphoma …

Diffuse large B-cell lymphoma (DLBCL) forms a heterogeneous collection of aggressive non-
Hodgkin's Lymphoma in which three principle classes of neoplasia have been defined …

Survivin is an inhibitor of apoptosis whose expression may be associated with inferior
outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated without rituximab …

The soluble decoy receptor 3 (DcR3) is a member of the tumor necrosis factor receptor
superfamily whose overexpression has been observed in several human malignancies …

Survivin is one of the inhibitors of apoptosis proteins (IAP) that might play an important role
in the pathogenesis of diffuse large B cell lymphoma (DLBCL). The present study was …

Inner centromere protein (INCENP) is a member of the Chromosomal Passenger Complex
(CPC), which is a four member protein complex essential for proper completion of mitosis …

Introducción: la inclusión del rituximab para el tratamiento del linfoma B difuso de células
grandes generó la necesidad de reevaluar los factores pronósticos que se empleaban …